The committee will discuss, make recommendations, and vote on a premarket approval application, sponsored by Medical Enterprises, Ltd., for a drug/device combination product designed to prevent recurrence of bladder cancer. Synergo SB-TS 101.1 Device...
Source: http://www.fda.gov/cdrh/newpg.html
Food and Drug Adminstration (FDA): CDRHNew